Curis Lifesciences IPO
CURIS
Open Date
07 Nov '25
Close Date
11 Nov '25
Price Range
₹120 - ₹128
Min Investment
₹2,56,000
Lot Size
1,000
Listing at
NSE
Issue Size
15,41,000
IPO Document
Free Demat with Zero AMC*
About Curis Lifesciences Ltd IPO
Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products.
The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing.
The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.
Products:
- General pharmaceutical tablets and capsules
- Oral liquids
- External preparations
- Sterile ophthalmic ointments
The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, adhering to stringent quality control measures to ensure product safety and efficacy.
As of July 31, 2025, the company has 95 permanent employees.
Competitive Strengths:
- Experienced Promoters and Management Team
- Wide range of Products
- Strategic Location of Manufacturing Facility
- Scalable Business Model
- Quality assurance
Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products. The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing. The company serves over 100 corporate clients on loan lice
Curis Lifesciences IPO Subscription Breakdown
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 7,70,500 crores |
| Non-Institutional Investors (NIIs) | 15% | 2,31,150 crores |
| Retail Individual Investors (RIIs) | 35% | 5,39,350 crores |
Curis Lifesciences IPO Strengths & Weaknesses
No Data Found
Curis Lifesciences IPO Important Dates & Issue Details
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 12 Nov '25 | 14 Nov '25 | 13 Nov '25 |
| Issue Composition: | |
|---|---|
| Face Value | ₹0 per share |
| Total Issue Size | 15,41,000 shares (aggregating up to ₹2,56,000 crores) |
| Fresh Issue | NaN shares (aggregating up to To be announced) |
| Offer for Sale | NaN shares of ₹0 (aggregating up to To be announced) |
| Issue Type | |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | shares |
| Post-Issue Shareholding | 0 shares |
Curis Lifesciences IPO Lot Size and Investment Details
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Curis Lifesciences ipo has been designed to ensure broad participation while maintaining optimal price discovery.
How to Apply for Curis Lifesciences IPO
- Log in to your Choice account
- Select IPO
- Enter the number of lots and your price
- Verify UPI ID
- Complete the transaction on your UPI app
Optivalue Tek Consulting Ltd IPO Lead Manager(s)
| Book Running Lead Manager(s) |
|---|